“A new long-acting treatment (‘Qfitlia’ or fitusiran) for hemophilia was approved. Patients tend to rely on regular infusions of clotting products or similar products to prevent excessive bleeding. This new treatment..is given by injection roughly once per two months. In phase 3 trials, it reduced bleeding episodes by around 70% more than standard treatment,” reports The Doomslayer.
Read Full Article: https://libertyunyielding.com/2026/01/08/new-treatment-for-hemophilia-cuts-bleeding-by-a-lot/
